Henry Schein, Inc. (NASDAQ:HSIC) Holdings Lowered by Johnson Financial Group Inc.

Johnson Financial Group Inc. trimmed its stake in shares of Henry Schein, Inc. (NASDAQ:HSICFree Report) by 23.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 7,268 shares of the company’s stock after selling 2,197 shares during the period. Johnson Financial Group Inc.’s holdings in Henry Schein were worth $550,000 as of its most recent SEC filing.

Several other hedge funds have also modified their holdings of HSIC. Aurora Investment Counsel lifted its stake in Henry Schein by 0.7% in the 3rd quarter. Aurora Investment Counsel now owns 20,641 shares of the company’s stock worth $1,533,000 after acquiring an additional 140 shares in the last quarter. Arizona State Retirement System lifted its stake in Henry Schein by 0.4% in the 4th quarter. Arizona State Retirement System now owns 35,890 shares of the company’s stock worth $2,717,000 after acquiring an additional 149 shares in the last quarter. Allspring Global Investments Holdings LLC lifted its stake in Henry Schein by 1.8% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 10,798 shares of the company’s stock worth $802,000 after acquiring an additional 194 shares in the last quarter. Wahed Invest LLC lifted its stake in Henry Schein by 11.3% in the 3rd quarter. Wahed Invest LLC now owns 2,035 shares of the company’s stock worth $151,000 after acquiring an additional 206 shares in the last quarter. Finally, Keybank National Association OH lifted its stake in Henry Schein by 1.8% in the 3rd quarter. Keybank National Association OH now owns 12,558 shares of the company’s stock worth $932,000 after acquiring an additional 219 shares in the last quarter. 96.62% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at Henry Schein

In other Henry Schein news, CEO Bradford C. Connett sold 6,430 shares of the firm’s stock in a transaction that occurred on Wednesday, March 20th. The stock was sold at an average price of $74.28, for a total value of $477,620.40. Following the sale, the chief executive officer now owns 73,108 shares of the company’s stock, valued at approximately $5,430,462.24. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. In other news, Vice Chairman James P. Breslawski sold 2,907 shares of Henry Schein stock in a transaction that occurred on Monday, March 18th. The stock was sold at an average price of $74.37, for a total transaction of $216,193.59. Following the sale, the insider now owns 209,562 shares of the company’s stock, valued at approximately $15,585,125.94. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Bradford C. Connett sold 6,430 shares of Henry Schein stock in a transaction that occurred on Wednesday, March 20th. The stock was sold at an average price of $74.28, for a total value of $477,620.40. Following the sale, the chief executive officer now directly owns 73,108 shares in the company, valued at approximately $5,430,462.24. The disclosure for this sale can be found here. Insiders own 1.14% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts recently issued reports on the company. TheStreet raised Henry Schein from a “c+” rating to a “b-” rating in a research note on Monday, February 26th. JPMorgan Chase & Co. upped their target price on Henry Schein from $82.00 to $88.00 and gave the stock an “overweight” rating in a research report on Wednesday, March 6th. Leerink Partnrs reaffirmed a “market perform” rating on shares of Henry Schein in a research report on Monday, February 26th. Piper Sandler upped their target price on Henry Schein from $78.00 to $86.00 and gave the stock an “overweight” rating in a research report on Monday, February 26th. Finally, Evercore ISI upped their target price on Henry Schein from $79.00 to $83.00 and gave the stock an “in-line” rating in a research report on Wednesday, February 28th. One analyst has rated the stock with a sell rating, six have assigned a hold rating and five have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $81.73.

Get Our Latest Stock Analysis on HSIC

Henry Schein Stock Up 0.3 %

Shares of NASDAQ HSIC traded up $0.20 during mid-day trading on Friday, reaching $71.72. 458,504 shares of the company traded hands, compared to its average volume of 1,089,650. The company has a debt-to-equity ratio of 0.47, a quick ratio of 1.02 and a current ratio of 1.75. The stock has a market cap of $9.18 billion, a PE ratio of 24.23, a price-to-earnings-growth ratio of 1.80 and a beta of 0.87. The company’s fifty day moving average is $72.49 and its two-hundred day moving average is $72.96. Henry Schein, Inc. has a fifty-two week low of $60.01 and a fifty-two week high of $82.63.

Henry Schein (NASDAQ:HSICGet Free Report) last released its earnings results on Tuesday, May 7th. The company reported $1.10 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.01 by $0.09. The firm had revenue of $3.17 billion for the quarter, compared to analyst estimates of $3.21 billion. Henry Schein had a return on equity of 13.51% and a net margin of 3.12%. The company’s revenue was up 3.7% on a year-over-year basis. During the same quarter last year, the firm posted $1.21 EPS. On average, analysts expect that Henry Schein, Inc. will post 5.08 earnings per share for the current year.

About Henry Schein

(Free Report)

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Featured Articles

Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSICFree Report).

Institutional Ownership by Quarter for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.